Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02770300 : Effect of Personalized Robotic Therapy
PhaseN/A
AgesMin: 18 Years Max: 100 Years
Eligibility
Inclusion Criteria:

- stroke patients

- right and left hand dominant

- cerebral lesion onset between 2-8 weeks

- able to participate in a session of about 30-60 minutes

- right-hemiplegic with at least 10° of motion in the treated joints (shoulder and
elbow)

- age: more than 18 years old

Exclusion Criteria:

- subjects with an active implantable device or wearing an active device (e.g.,
pacemakers, metallic objects in the brain, infusion pumps, etc.)

- persistent delirium or disturbed vigilance

- moderate or severe language comprehension deficits

- skull breach

- new stroke lesions during rehabilitation

- patients incapable of discernment

- subjects with reduced mobility due to previous injuries or abnormalities unrelated
with the cerebral accident
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02770300      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740